End-of-day quote
Shanghai S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
13.19
CNY
|
+1.23%
|
|
+0.23%
|
-45.27%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,521
|
2,356
|
4,109
|
9,248
|
6,826
|
4,850
|
Enterprise Value (EV)
1 |
1,467
|
2,070
|
3,848
|
8,899
|
6,503
|
4,556
|
P/E ratio
|
46.4
x
|
44.7
x
|
81.7
x
|
164
x
|
339
x
|
92.7
x
|
Yield
|
2.65%
|
1.71%
|
0.94%
|
0.39%
|
0.44%
|
-
|
Capitalization / Revenue
|
3.88
x
|
5.71
x
|
9.9
x
|
23.4
x
|
16.9
x
|
12.3
x
|
EV / Revenue
|
3.74
x
|
5.02
x
|
9.27
x
|
22.5
x
|
16.1
x
|
11.6
x
|
EV / EBITDA
|
31.1
x
|
30.4
x
|
59.2
x
|
402
x
|
269
x
|
173
x
|
EV / FCF
|
-10.8
x
|
9.82
x
|
157
x
|
-285
x
|
-692
x
|
-88.2
x
|
FCF Yield
|
-9.26%
|
10.2%
|
0.64%
|
-0.35%
|
-0.14%
|
-1.13%
|
Price to Book
|
2.39
x
|
3.61
x
|
6.54
x
|
13.5
x
|
10.2
x
|
7.04
x
|
Nbr of stocks (in thousands)
|
201,227
|
201,227
|
201,227
|
201,227
|
201,227
|
201,227
|
Reference price
2 |
7.557
|
11.71
|
20.42
|
45.96
|
33.92
|
24.10
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/27/21
|
4/27/22
|
4/27/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
392.4
|
412.7
|
415
|
395.9
|
404.2
|
393.6
|
EBITDA
1 |
47.15
|
68.2
|
64.98
|
22.14
|
24.2
|
26.31
|
EBIT
1 |
29.89
|
52.9
|
50.46
|
7.473
|
8.956
|
9.499
|
Operating Margin
|
7.62%
|
12.82%
|
12.16%
|
1.89%
|
2.22%
|
2.41%
|
Earnings before Tax (EBT)
1 |
37.48
|
61.12
|
59.07
|
65
|
23.25
|
63.6
|
Net income
1 |
32.8
|
52.53
|
49.78
|
55.69
|
19.72
|
52.02
|
Net margin
|
8.36%
|
12.73%
|
12%
|
14.07%
|
4.88%
|
13.22%
|
EPS
2 |
0.1630
|
0.2621
|
0.2500
|
0.2800
|
0.1000
|
0.2600
|
Free Cash Flow
1 |
-135.9
|
210.7
|
24.53
|
-31.27
|
-9.403
|
-51.68
|
FCF margin
|
-34.62%
|
51.06%
|
5.91%
|
-7.9%
|
-2.33%
|
-13.13%
|
FCF Conversion (EBITDA)
|
-
|
309.02%
|
37.75%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
401.21%
|
49.27%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2000
|
0.2000
|
0.1929
|
0.1800
|
0.1500
|
-
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/27/21
|
4/27/22
|
4/27/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
53.4
|
286
|
261
|
349
|
322
|
293
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-136
|
211
|
24.5
|
-31.3
|
-9.4
|
-51.7
|
ROE (net income / shareholders' equity)
|
5.21%
|
8.17%
|
7.78%
|
8.49%
|
2.92%
|
7.67%
|
ROA (Net income/ Total Assets)
|
2.54%
|
4.41%
|
4.08%
|
0.58%
|
0.67%
|
0.7%
|
Assets
1 |
1,291
|
1,191
|
1,219
|
9,660
|
2,934
|
7,388
|
Book Value Per Share
2 |
3.160
|
3.240
|
3.120
|
3.400
|
3.320
|
3.420
|
Cash Flow per Share
2 |
0.4400
|
0.4400
|
0.6600
|
1.090
|
0.7100
|
1.210
|
Capex
1 |
31.4
|
45.2
|
34.2
|
54.5
|
26.9
|
64.1
|
Capex / Sales
|
7.99%
|
10.96%
|
8.25%
|
13.77%
|
6.64%
|
16.3%
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/27/21
|
4/27/22
|
4/27/23
|
3/27/24
|
|
1st Jan change
|
Capi.
|
---|
| -45.27% | 366M | | +17.07% | 66.31B | | +0.18% | 48.46B | | +20.03% | 43.27B | | +27.43% | 27.41B | | +8.08% | 19.26B | | -2.14% | 16.61B | | +8.54% | 16.58B | | -15.01% | 14.41B | | -30.22% | 14.02B |
Other Specialty Chemicals
|